OKT3 MONOCLONAL-ANTIBODY PLASMA-LEVELS DURING THERAPY AND THE SUBSEQUENT DEVELOPMENT OF HOST ANTIBODIES TO OKT3

被引:152
作者
GOLDSTEIN, G
FUCCELLO, AJ
NORMAN, DJ
SHIELD, CF
COLVIN, RB
COSIMI, AB
机构
[1] MASSACHUSETTS GEN HOSP,BOSTON,MA 02114
[2] OREGON HLTH SCI UNIV,PORTLAND,OR 97201
[3] ST FRANCIS REG MED CTR,WICHITA,KS 67214
关键词
D O I
10.1097/00007890-198611000-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:507 / 511
页数:5
相关论文
共 27 条
[1]   UNUSUALLY RESTRICTED ANTI-ISOTYPE HUMAN IMMUNE-RESPONSE TO OKT3 MONOCLONAL-ANTIBODY [J].
BAUDRIHAYE, MF ;
CHATENOUD, L ;
KREIS, H ;
GOLDSTEIN, G ;
BACH, JF .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (08) :686-691
[2]   DISTINCT EPITOPES ON THE T8 MOLECULE ARE DIFFERENTIALLY INVOLVED IN CYTO-TOXIC T-CELL FUNCTION [J].
BIDDISON, WE ;
RAO, PE ;
TALLE, MA ;
BOSELLI, CM ;
GOLDSTEIN, G .
HUMAN IMMUNOLOGY, 1984, 9 (02) :117-130
[3]   POSSIBLE INVOLVEMENT OF THE T4-MOLECULE IN T-CELL RECOGNITION OF CLASS-II HLA ANTIGENS - EVIDENCE FROM STUDIES OF CTL-TARGET CELL BINDING [J].
BIDDISON, WE ;
RAO, PE ;
TALLE, MA ;
GOLDSTEIN, G ;
SHAW, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (03) :783-797
[4]  
CARPENTER CB, 1983, T ASSOC AM PHYSICIAN, V16, P84
[5]   DOES OKT3 MONOCLONAL-ANTIBODY REACT WITH AN ANTIGEN-RECOGNITION STRUCTURE ON HUMAN T-CELLS [J].
CHANG, TW ;
KUNG, PC ;
GINGRAS, SP ;
GOLDSTEIN, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (03) :1805-1808
[6]  
CHATENOUD L, 1985, TRANSPLANT P, V17, P558
[7]   HUMAN INVIVO ANTIGENIC MODULATION INDUCED BY THE ANTI-T-CELL OKT3 MONOCLONAL-ANTIBODY [J].
CHATENOUD, L ;
BAUDRIHAYE, MF ;
KREIS, H ;
GOLDSTEIN, G ;
SCHINDLER, J ;
BACH, JF .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1982, 12 (11) :979-982
[8]  
COLVIN R, 1981, 8TH INT C NEPHR P AT, P990
[9]  
CUPPS TR, 1982, J IMMUNOL, V128, P2453
[10]   THERAPY OF CHRONIC LYMPHOCYTIC-LEUKEMIA AND CUTANEOUS T-CELL LYMPHOMA WITH T101 MONOCLONAL-ANTIBODY [J].
DILLMAN, RO ;
SHAWLER, DL ;
DILLMAN, JB ;
ROYSTON, I .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (08) :881-891